OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Stephen Strittmater

1 Projects | 1 Researchers | $267,928 Invested

2001

Yale University

Stephen Strittmater, PhD

Nogo Antagonists in Axon Regeneration and Plasticity

  • Funding Amount: $267,928
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed